Indian Pharma Companies, especially the ones focusing on generics, have a lot to cheer about. This is because of the surge in the number of big branded drugs losing patents. As today's chart of the day shows, the average value of drugs losing patents is way ahead in the coming 4 years as compared to the last 2 decades. That said, competition has also increased and it will be interesting to see what each player does to keep one step ahead of the other.


Data Source: Biocon annual report